Assessing risks for gastric cancer: New tools for pathologists

World Journal of Gastroenterology

Volumn 12, Issue 35, 2006, Pages 5622-5627

  Genta, Robert M ^a,c   Rugge, Massimo ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Gastritis; Gastritis histology; Staging and grading

Indexed keywords

GASTRIN; PEPSINOGEN;

ATROPHY; CANCER GRADING; CANCER RISK; CANCER STAGING; CHRONIC GASTRITIS; DISEASE CLASSIFICATION; DYSPLASIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; NONHUMAN; PREDICTION; REVIEW; RISK ASSESSMENT; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH LESION; STOMACH MUCOSA;

EID: 33750120296     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i35.5622     Document Type: Review

References (73)

1. Genta RM. Inflammatory Disorders of the Stomach. In: Odze RD, Goldblum JR, Crawford DH, editors. Surgical Pathology of the GI TRact, Liver, Biliary Tract, and Pancreas. Philadelphia: Saunders, 2004:143-176
2. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-3560
3. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241
4. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, Brown C, Haenszel W. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976; 57: 1027-1035
5. Sipponen P, Kekki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer 1983; 52: 1062-1068
6. You WC, Zhang L, Gail MH, Li JY, Chang YS, Blot WJ, Zhao CL, Liu WD, Li HQ, Ma JL, Hu YR, Bravo JC, Correa P, Xu GW, Fraumeni JF Jr. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998; 27: 945-948
7. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004; 157: 301-310
8. Maaroos HI, Kekki M, Sipponen P, Salupere V, Villako K. Grade of Helicobacter pylori colonisation, chronic gastritis and relative risks of contracting high gastric ulcers: a seven-year follow-up. Scand J Gastroenterol Suppl 1991; 186: 65-72
9. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-177
10. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000; 95: 1431-1438
11. Price AB, Misiewicz JJ. Sydney classification for gastritis. Lancet 1991; 337: 174
12. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
13. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, Watanabe H, Genta RM. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-1259
14. Ihamaki T, Saukkonen M, Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23 - 27 years' follow-up examinations. Scand J Gastroenterol 1978; 13: 771-775
15. Ihamaki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol 1985; 20: 485-491
16. Kekki M, Ihamaki T, Varis K, Isokoski M, Lehtola J, Hovinen E, Siurala M. Age of gastric cancer patients and susceptibility to chronic gastritis in their relatives. A mathematical approach using Poisson's process and scoring of gastritis state. Scand J Gastroenterol 1973; 8: 673-679
17. Kekki M, Villako K, Tamm A, Siurala M. Dynamics of antral and fundal gastritis in an Estonian rural population sample. Scand J Gastroenterol 1977; 12: 321-324
18. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, Brown C, Haenszel W. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976; 57: 1027-1035
19. Cuello C, Correa P, Haenszel W, Gordillo G, Brown C, Archer M, Tannenbaum S. Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst 1976; 57: 1015-1020
20. Haenszel W, Correa P, Cuello C, Guzman N, Burbano LC, Lores H, Munoz J. Gastric cancer in Colombia. II. Case-control epidemiologic study of precursor lesions. J Natl Cancer Inst 1976; 57: 1021-1026
21. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: 584-592
22. Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986; 57: 1528-1534
23. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol Suppl 1984; 104: 131-136
24. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315
25. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740
26. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
27. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, Riddell RH, Sipponen P, Watanabe H. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-176
28. Kekki M, Ihamaki T, Varis K, Siurala M. Chronic gastritis profiles in sibs of probands calculated to carry a highly increased risk of gastric carcinoma. Scand J Gastroenterol Suppl 1991; 186: 29-32
29. Bonney GE, Elston RC, Correa P, Haenszel W, Zavala DE, Zarama G, Collazos T, Cuello C. Genetic etiology of gastric carcinoma: I. Chronic atrophic gastritis. Genet Epidemiol 1986; 3: 213-224
30. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Indiviual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88: 274-279
31. Ihamaki T. Susceptibility to chronic gastritis in first degree relatives of gastric carcinoma patients. Effect of histological type of carcinoma and location of tumour. Ann Clin Res 1984; 16: 183-187
32. Ruiz B, Garay J, Johnson W, Li D, Rugge M, Dixon MF, Fiocca R, Genta RM, Hattori T, Lechago J, Price AB, Sipponen P, Solcia E, Watanabe H, Correa P. Morphometric assessment of gastric antral atrophy: comparison with visual evaluation. Histopathology 2001; 39: 235-242
33. Ihamaki T, Sipponen P, Varis K, Kekki M, Siurala M. Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterol Suppl 1991; 186: 16-23
34. Siurala M, Kekki M, Varis K, Isokoski M, Ihamaki T. Gastritis and gastric cancer. Br Med J 1972; 3: 530-531
35. Correa P. Helicobacter pylori and gastric cancer: state of the art. Cancer Epidemiol Biomarkers Prev 1996; 5: 477-481
36. Miehlke S, Hackelsberger A, Meining A, Hatz R, Lehn N, Malfertheiner P, Stolte M, Bayerdorffer E. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998; 78: 263-266
37. Walker IR, Strickland RG, Ungar B, Mackay IR. Simple atrophic gastritis and gastric carcinoma. Gut 1971; 12: 906-911
38. Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997; 29: 671-678
39. Jass JR, Filipe MI. Sulphomucins and precancerous lesions of the human stomach. Histopathology 1980; 4: 271-279
40. Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J1981; 13: 931-939
41. Tosi P, Filipe MI, Luzi P, Miracco C, Santopietro R, Lio R, Sforza V, Barbini P. Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry. J Pathol 1993; 169: 73-78
42. Filipe MI, Potet F, Bogomoletz WV, Dawson PA, Fabiani B, Chauveinc P, Fenzy A, Gazzard B, Goldfain D, Zeegen R. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985; 26: 1319-1326
43. Filipe MI, Munoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Teuchmarm S, Benz M, Prijon T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 324-329
44. Leung WK, Sung JJ, Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002; 16: 1209-1216
45. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications, Hum Pathol 1983; 14: 931-968
46. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994; 25: 982-993
47. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19:166-178
48. Ming SC, Bajtai A, Correa P, Elster K, Jarvi OH, Munoz N, Nagayo T, Stemmerman GN. Gastric dysplasia. Significance and pathologic criteria. Cancer 1984; 54: 1794-1801
49. Genta RM. Gastric Dysplasia in the East and West. Current Gastroenterology Reports 2; In press
50. Schlemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, Stolte M, Watanabe H, Takahashi H, Fujita R. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 1997; 349: 1725-1729
51. Fenoglio-Preiser CM, Carneiro F, Correa P, Guilford P, Lambert R, Megraud F et al. Gastric carcinoma. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Digestive System. Lyon: LARC Press, 2000: 37-68
52. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, Riddell RH, Sipponen P, Watanabe H. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-176
53. Schlemper RJ, Kato Y, Stolte M. Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol 2000; 15 Suppl: G49-G57
54. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. 1st ed. English Edition. Tokyo: Kanehara & Co., Ltd., 1995
55. El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 1999; 30: 72-77
56. Rugge M, Farinati F, Baffa R, Sonego F, Di Mario F, Leandro G, Valiante F. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology 1994; 107: 1288-1296
57. Rugge M, Cassaro M, Di Mario F, Leo G, Leandro G, Russo VM, Pennelli G, Farinati F. The long term outcome of gastric non-invasive neoplasia. Gut 2003; 52: 1111-1116
58. Genta RM, Graham DY. Primary gastric MALT lymphoma: trivial condition or serious disease? Helicobacter 1997; 2 Suppl 1: S56-S60
59. Korstanje A, den Hartog G, Biemond I, Lamers CB. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl 2002; 236: 22-26
60. Di Mario F, Kusstatscher S, Ferrana M, Dal Bo' N, Plebani M, Rugge M. Helicobacter pylori eradication and serum pepsinogens. Gut 1996; 38: 793
61. Di Mario F, Moussa AM, Caruana P, Merli R, Cavallaro LG, Cavestro GM, Dal Bo N, Iori V, Pilotto A, Leandro G, Franze A, Rugge M. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003; 38: 1223-1227
62. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002; 48: 505-515
63. Mardh E, Mardh S, Mardh B, Borch K. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002; 320: 17-27
64. Plebani M, Di Mario F, Vianello F, Farini R, Piccoli A, Lazzaretto L, Perobelli L, Naccarato R, Burlina A. Actual role of pepsinogen group I in the study of upper gastrointestinal diseases. Clin Biochem 1983; 16: 310-312
65. Plebani M, Di Mario F, Stanghellini V, Delle Fave G. Serological tests to monitor treatment of Helicobacter pylori. Lancet 1992; 340: 51-52
66. Farinati F, Di Mario F, Plebani M, Cielo R, Fanton MC, Valiante F, Masiero M, De Boni M, Della Libera G, Burlina A. Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer? Ital J Gastroenterol 1991; 23: 194-196
67. Varis K, Kekki M, Harkonen M, Sipponen P, Samloff IM. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol Suppl 1991; 186: 117-123
68. Varis K, Sipponen P, Laxen F, Samloff IM, Huttunen JK, Taylor PR, Heinonen OP, Albanes D, Sande N, Virtamo J, Harkonen M. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol 2000; 35: 950-956
69. Germana B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franze A. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 2005; 37: 501-508
70. ISI Web of Science-Citation Index. Science Citation Index Expanded (SCI-Expanded)-1945-present, 2004
71. Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005; 36: 228-233
72. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520
73. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699